Orthopedics drugs

1 result
Ipsen Biopharmaceuticals, Inc.
Usage: SOHONOS is indicated for reducing the volume of new heterotopic ossification in adults and pediatric patients (8 years and older for females, 10 years and older for males) diagnosed with fibrodysplasia ossificans progressiva (FOP).